Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma

European Journal of Clinical Investigation

Volumn 38, Issue 10, 2008, Pages 713-720

  Erridge, C ^a,e   Burdess, A ^b   Jackson, A J ^c   Murray, C ^d   Riggio, M ^d   Lappin, D ^d   Milligan, S ^d   Spickett, C M ^c   Webb, D J ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

16S gene; Atherosclerosis; Bacteria; Toll like receptor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOSINE; DNA 16S; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLAGELLIN; INTERLEUKIN 8; LIGAND; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LOXORIBINE; MESSENGER RNA; POLYINOSINIC ACID; PRIMER DNA; SINGLE STRANDED RNA; TISSUE EXTRACT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BACTERIAL CELL; BACTERIAL GENOME; BACTERIUM; BLOOD VESSEL; CAROTID ARTERY; CELL STRAIN HEK293; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE RELEASE; DNA EXTRACTION; DNA SEQUENCE; ENDOTHELIUM CELL; GENE AMPLIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INFLAMMATION; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STIMULUS RESPONSE; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CELL LINE; DNA PRIMERS; DNA, BACTERIAL; E-SELECTIN; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; LIGANDS; MYOCYTES, SMOOTH MUSCLE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TRANSFECTION;

EID: 52149089441     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02010.x     Document Type: Article

References (36)

1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999 138 : S419 20.
2. Tobias P, Curtiss LK. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res 2005 46 : 404 11.
3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 2001 413 : 732 8.
4. McGettrick AF, O'Neill LA. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol Immunol 2004 41 : 577 82.
5. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signalling pathways. Nat Med 2004 10 : 416 21.
6. Michelson KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004 101 : 10679 84.
7. Liu X, Ukai T, Yumoto H, Davey M, Goswami S, Gibson III FC et al. Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis 2008 196 : 146 54.
8. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005 115 : 3149 56.
9. Lehr HA, Sagban TA, Ihling C, Zahringer U, Hungerer KD, Blumrich M et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 2001 104 : 914 20.
10. Schoneveld AH, Oude Nijhuis MM, van Middelaar B, Laman JD, de Kleijn DP, Pasterkamp G. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res 2005 66 : 162 9.
11. Edfeldt K, Swedenborg J, Hansson GK, Yan Z. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002 105 : 1158 60.
12. Laman JD, Schoneveld AH, Moll FL, van Meurs M, Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am J Cardiol 2002 90 : 119 23.
13. Meijer A, Roholl PJ, Gielis-Proper SK, Ossewaarde JM. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. J Clin Pathol 2000 53 : 911 6.
14. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006 113 : 929 37.
15. Lehtiniemi J, Karhunen PJ, Goebeler S, Nikkari S, Nikkari ST. Identification of different bacterial DNAs in human coronary arteries. Eur J Clin Invest 2005 35 : 13 6.
16. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989 261 : 3561 6.
17. Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 2000 160 : 2027 32.
18. Delahooke D, Barclay G, Poxton I. TNF-α induction by an aqeous phenol-extracted lipopolysaccharide complex from Bacteroides species. Infect Immun 1996 63 : 840 6.
19. Dempsey KE, Riggio MP, Lennon A, Hannah VE, Ramage G, Allan D et al. Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture. Arthritis Res Ther 2007 9 : R46.
20. Erridge C, Spickett CM, Webb DJ. Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2. Cardiovasc Res 2007 73 : 181 9.
21. Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005 174 : 1259 68.
22. Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004 24 : 1503 8.
23. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-Selectin or intercellular adhesion molecule (ICAM) -1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000 191 : 189 94.
24. Maaser C, Heidemann J, Eiff CV, Lugering A, Spahn TW, Binion DG et al. Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J Immunol 2004 172 : 5056 62.
25. Dunzendorfer S, Lee HK, Tobias PS. Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ Res 2004 95 : 684 91.
26. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001 103 : 1064 70.
27. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000 102 : 833 9.
28. Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel HM et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurisms. J Vasc Surg 1997 25 : 499 505.
29. Vink A, Poppen M, Schoneveld AH, Roholl PJM, de Kleijn DPV, Borst C et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 2001 103 : 1613 7.
30. Fiehn NE, Larsen T, Christiansen N, Holmstrup P, Schroeder TV. Identification of periodontal pathogens in atherosclerotic vessels. J Periodontol 2005 76 : 731 6.
31. Erwin AL, Munford RS. Deacylation of structurally diverse lipopolysaccharides by human acyloxyacyl hydrolase. J Biol Chem 1990 265 : 16444 9.
32. Poppert S, Schlaupitz K, Marre R, Voisard R, Roessler W, Weckermann D et al. Chlamydia pneumoniae in an ex vivo human artery culture model. Atherosclerosis 2006 187 : 50 6.
33. van der Heijden IM, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, Hazenberg MP et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arth Rheum 2000 43 : 593 8.
34. Kozarov E, Sweier D, Shelburne C, Progulske-Fox A, Lopatin D. Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect 2006 8 : 687 93.
35. Okuda K, Ishihara K, Nakagawa T, Hirayama A, Inayama Y, Okuda K. Detection of Treponema denticola in atherosclerotic lesions. J Clin Microbiol 2001 39 : 1114 7.
36. Renko J, Lepp PW, Oksala N, Nikkari S, Nikkari ST. Bacterial signatures in atherosclerotic lesions represents human commensals and pathogens. Atherosclerosis 2008 [epub ahead of print] doi:., 2008.01.006.